Article Information
History
- September 3, 2024.
Article Versions
- Version 1 (May 18, 2024 - 10:00).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Art Schuermans1,2,3,*,
- Andreas Verstraete1,4,
- Vilma Lammi5,
- Tomoko Nakanishi6,7,8,9,10,
- Maddalena Ardissino11,12,
- Jef Van den Eynde1,
- Benjamin B. Sun13,
- Marios K. Georgakis2,14,15,
- Johan Van Weyenbergh16,
- Adam J. Lewandowski17,
- Betty Raman18,
- Hanna M. Ollila2,3,5,19,
- Stephen Burgess20,
- Pradeep Natarajan2,3,21,
- Michael C. Honigberg2,3,21,
- Kathleen Freson1,
- Thomas Vanassche1,4 and
- Peter Verhamme1,4
- 1KU Leuven Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, Leuven, Belgium
- 2Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- 3Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
- 4UZ Leuven Department of Cardiovascular Diseases, Leuven, Belgium
- 5Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
- 6Department of Human Genetics, McGill University, Montréal, QC, Canada
- 7Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, QC, Canada
- 8Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
- 9Department of Genome Informatics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan
- 10Japan Society for the Promotion of Science, Tokyo, Japan
- 11BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- 12National Heart and Lung Institute, Imperial College London, London, UK
- 13Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- 14Institute for Stroke and Dementia Research, Ludwig Maximilian University of Munich, Munich, Germany
- 15Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- 16Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium
- 17Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 18Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
- 19Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, USA
- 20MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
- 21Department of Medicine, Harvard Medical School, Boston, MA, USA
- ↵*Correspondence to
: Art Schuermans, KU Leuven Department of Cardiovascular Sciences, Center of Molecular and Vascular Biology, Herestraat 49 (box 911), 3000 Leuven, Belgium, Tel: +32 16 343491, Fax: +32 16 343493, Email: aschuerm{at}broadinstitute.org
Posted September 03, 2024.
WITHDRAWN: Proteogenomic analyses identify coagulation factor XI as a thromboinflammatory mediator of long COVID
